Last reviewed · How we verify
HRE
HRE's mechanism of action is not well-documented.
At a glance
| Generic name | HRE |
|---|---|
| Sponsor | Indian Council of Medical Research |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Unfortunately, there is limited information available on HRE's mechanism of action, making it difficult to provide a detailed explanation.
Approved indications
Common side effects
Key clinical trials
- Neuroinflammation in FTLD
- Community-associated Highly-Resistant Enterobacterales
- Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial (PHASE3)
- Intensified Short Course Regimen for TBM in Adults (PHASE3)
- Study of the Neural Substrates of Alcohol Craving by High-resolution Electroencephalography (NA)
- Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study) (NA)
- Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis (NA)
- Protonics Knee Brace Versus Hamstring Resisted Exercise (HRE) on Individuals With Patellofemoral Pain Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HRE CI brief — competitive landscape report
- HRE updates RSS · CI watch RSS
- Indian Council of Medical Research portfolio CI